+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Cytology and HPV Testing Market (2022-2027) by Test Type, Application, End-User, and Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis

  • PDF Icon

    Report

  • 192 Pages
  • September 2022
  • Region: Global
  • Infogence Global Research
  • ID: 5669274

Cervical cancer is the second most common type of cancer in women, preceded by breast cancer.HPV contributes to around 90% of all anal and cervical cancers and 70% of vaginal and vulvar cancers

The Global Cytology and HPV Testing Market is estimated to be USD 11.05 Bn in 2022 and is expected to reach USD 14.93 Bn by 2027, growing at a CAGR of 6.2%

Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding growth and reducing risks.

Market Segmentations

The Global Cytology and HPV Testing Market are segmented based on Test Type, Application, End-User, and Geography.

  • By Test Type, the market is classified into HPV Testing and Cytology Testing.
  • By Product Type, the market is classified into Instruments, Consumables, and Services.
  • By Technology Type, the market is classified into Instruments, Consumables, and Services.
  • By Product Type, the market is classified into PCR, Immunodiagnostics, and Other
  • By Application, the market is classified into Cervical Cancer Screening and Vaginal Cancer Screening.
  • By End-User, the market is classified into Laboratories, Hospitals & Clinics, and Physician’s Offices.
  • By Geography, the market is classified into the Americas, Europe, Middle East & Africa, and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Abbott Laboratories, Inc., Agilent Technologies, Inc., Becton, Dickinson & Company, CellPath, Ltd., Danaher Corp., F. Hoffmann-La Roche Ltd., GlaxoSmithKline, PLC, etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

The report presents a detailed Ansoff matrix analysis for the Global Cytology and HPV Testing Market. Ansoff Matrix, also known as the Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.

The analyst analyses the Global Cytology and HPV Testing Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.

Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Cytology and HPV Testing Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains a competitive analysis using Positioning Quadrants, the analyst's competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including the parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global Cytology and HPV Testing Market

What is the estimated value of the Global Cytology and HPV Testing Market?

The Global Cytology and HPV Testing Market was estimated to be valued at $11.05 Billion in 2022.

What is the growth rate of the Global Cytology and HPV Testing Market?

The growth rate of the Global Cytology and HPV Testing Market is 6.2%, with an estimated value of $14.93 Billion by 2027.

What is the forecasted size of the Global Cytology and HPV Testing Market?

The Global Cytology and HPV Testing Market is estimated to be worth $14.93 Billion by 2027.

Who are the key companies in the Global Cytology and HPV Testing Market?

Key companies in the Global Cytology and HPV Testing Market include Abbott Laboratories, Inc., Agilent Technologies, Inc., Becton, Dickinson & Company, CellPath, Ltd., Danaher Corp., F. Hoffmann, La Roche, Ltd., GlaxoSmithKline, PLC, Hologic, Inc. and Medimeas.

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 IGR Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations, and Outlook
4 Market Dynamics
4.1 Drivers
4.1.1 Increasing Number of Cervical Cancer Cases and Growing Aging Population
4.1.2 Increasing Awareness of Cervical Cancer Screening Programs
4.2 Restraints
4.2.1 Frequent Changes in Regulatory Guidelines for Cervical Cancer Screening
4.2.2 Lack of Proper Healthcare Infrastructure
4.2.3 Presence of Outdated Facilities in Most of the Developing Countries
4.3 Opportunities
4.3.1 Increasing Investment in Healthcare Industry Worldwide
4.3.2 Advancement in Technology and Increasing Government Initiatives and Funding
4.4 Challenges
4.4.1 Limitations Oriented to the Complexities in Diagnosis

5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
5.5 PESTLE Analysis
6 Global Cytology and HPV Testing Market, By Test Type
6.1 Introduction
6.2 HPV Testing
6.2.1 Follow-up HPV Testing
6.2.2 Co-testing
6.2.3 HPV Primary testing
6.3 Cryptology Testing
7 Global Cytology and HPV Testing Market, By Product Type
7.1 Introduction
7.2 Instruments
7.3 Consumables
7.4 Services
8 Global Cytology and HPV Testing Market, By Technology Type
8.1 Introduction
8.2 PCR
8.3 Immunodiagnostics
8.4 Other
9 Global Cytology and HPV Testing Market, By Application
9.1 Introduction
9.2 Cervical Cancer Screening
9.3 Vaginal Cancer Screening
10 Global Cytology and HPV Testing Market, By End-User
10.1 Introduction
10.2 Laboratories
10.3 Hospitals & Clinics
10.4 Physician’s Offices
11 Americas’ Cytology and HPV Testing Market
11.1 Introduction
11.2 Argentina
11.3 Brazil
11.4 Canada
11.5 Chile
11.6 Colombia
11.7 Mexico
11.8 Peru
11.9 United States
11.10 Rest of Americas
12 Europe’s Cytology and HPV Testing Market
12.1 Introduction
12.2 Austria
12.3 Belgium
12.4 Denmark
12.5 Finland
12.6 France
12.7 Germany
12.8 Italy
12.9 Netherlands
12.10 Norway
12.11 Poland
12.12 Russia
12.13 Spain
12.14 Sweden
12.15 Switzerland
12.16 United Kingdom
12.17 Rest of Europe
13 Middle East and Africa’s Cytology and HPV Testing Market
13.1 Introduction
13.2 Egypt
13.3 Israel
13.4 Qatar
13.5 Saudi Arabia
13.6 South Africa
13.7 United Arab Emirates
13.8 Rest of MEA
14 APAC’s Cytology and HPV Testing Market
14.1 Introduction
14.2 Australia
14.3 Bangladesh
14.4 China
14.5 India
14.6 Indonesia
14.7 Japan
14.8 Malaysia
14.9 Philippines
14.10 Singapore
14.11 South Korea
14.12 Sri Lanka
14.13 Thailand
14.14 Taiwan
14.15 Rest of Asia-Pacific
15 Competitive Landscape
15.1 Competitive Quadrant
15.2 Market Share Analysis
15.3 Strategic Initiatives
15.3.1 M&A and Investments
15.3.2 Partnerships and Collaborations
15.3.3 Product Developments and Improvements
16 Company Profiles
16.1 Abbott Laboratories, Inc.
16.2 Agilent Technologies, Inc.
16.3 Becton, Dickinson & Company
16.4 CellPath, Ltd.
16.5 Danaher Corp.
16.6 F. Hoffmann-La Roche, Ltd.
16.7 GlaxoSmithKline, PLC
16.8 Hologic, Inc.
16.9 Medimeas
16.10 Merck KGaA
16.11 Novartis Ag
16.12 PerkinElmer, Inc.
16.13 Sysmex Corp.
16.14 Thermo Fisher Scientific, Inc.
16.15 Trivitron Healthcare
17 Appendix
17.1 Questionnaire

Companies Mentioned

  • Abbott Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson & Company
  • CellPath, Ltd.
  • Danaher Corp.
  • F. Hoffmann-La Roche, Ltd.
  • GlaxoSmithKline, PLC
  • Hologic, Inc.
  • Medimeas
  • Merck KGaA
  • Novartis Ag
  • PerkinElmer, Inc.
  • Sysmex Corp.
  • Thermo Fisher Scientific, Inc.
  • Trivitron Healthcare